董佳琳, 荆慧. 近红外光免疫治疗在乳腺癌治疗中的研究进展[J]. 中国肿瘤临床, 2023, 50(22): 1164-1167. DOI: 10.12354/j.issn.1000-8179.2023.20230902
引用本文: 董佳琳, 荆慧. 近红外光免疫治疗在乳腺癌治疗中的研究进展[J]. 中国肿瘤临床, 2023, 50(22): 1164-1167. DOI: 10.12354/j.issn.1000-8179.2023.20230902
Jialin Dong, Hui Jing. Research progress on near-infrared photoimmunotherapy for breast cancer treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(22): 1164-1167. DOI: 10.12354/j.issn.1000-8179.2023.20230902
Citation: Jialin Dong, Hui Jing. Research progress on near-infrared photoimmunotherapy for breast cancer treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(22): 1164-1167. DOI: 10.12354/j.issn.1000-8179.2023.20230902

近红外光免疫治疗在乳腺癌治疗中的研究进展

Research progress on near-infrared photoimmunotherapy for breast cancer treatment

  • 摘要: 在乳腺癌治疗过程中,内科治疗导致的耐药和手术造成的非必要创伤等问题较为常见,为此临床上一直致力于寻找一种具有精准性并且伤害较小的治疗手段。由于乳腺癌的难治性和多样性,针对不同种类的乳腺癌发现疗效显著的靶点,研究如何应用靶向治疗具有重要意义。近红外光免疫治疗(near-infrared photoimmunotherapy,NIR-PIT)可在近红外光的照射下,靶向性杀灭癌细胞并诱导人体产生持久的免疫反应,影响肿瘤的进展、转移和侵袭等生理过程。为乳腺癌靶向治疗提供进一步的参考,本文将对NIR-PIT的作用机制和特性及治疗乳腺癌的常见靶点进行综述。

     

    Abstract: During the treatment of breast cancer, common problems are drug resistance caused by medical treatments and non-essential trauma caused by surgery. Clinically, it is crucial to find a method to treat breast cancer, which is precise and less harmful. Due to the refractory nature and diversity of breast cancer, it is of great importance to study how to apply targeted therapies to find highly effective targets for different types of breast cancer. Near-infrared photoimmunotherapy (NIR-PIT) can specifically kill cancer cells and induce lasting immune responses in humans under NIR light irradiation, affecting physiological processes such as cancer progression, metastasis and invasion. This provides a further reference for the targeted therapy of breast cancer. This review provides an overview of the mechanisms and properties of NIR-PIT and common targets for the treatment of breast cancer.

     

/

返回文章
返回